Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Cancer 'Moonshot' Recommendations On R&D Have Strong Patient Focus

Executive Summary

Blue ribbon panel has plenty of industry-friendly recommendations on ways to accelerate oncology science, but with the clock ticking down on the Obama Administration, the question is whether the recommendations have any political traction.

Advertisement

Related Content

Cancer Moonshot To Tackle Hereditary Colon Cancer Screening
FDA's Pazdur Won't Become Oncology Bureaucrat: 'My Presence Will Be Felt'
Cancer “Moonshot” Launch Team Announced: Uncomfortable Ties To Anti-Industry Headlines
Cancer Moonshot Initiative: FDA To Form Virtual Oncology Center of Excellence
Biden’s Cancer Initiative May Intensify Industry, Government Collaboration

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS119106

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel